Serial Number | 79313763 |
Word Mark | RENNANO |
Filing Date | Wednesday, February 24, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 3, 2022 |
Registration Number | 6714941 |
Registration Date | Tuesday, May 3, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 15, 2022 |
Goods and Services | Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; medicines for human purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposes, namely, antibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases |
Goods and Services | Live trees; live plants; live animals; poultry, live; pigs, live; hamsters, live; live laboratory animals; plant seeds; fodder; litter for animals |
Goods and Services | Conducting early evaluation in the field of new pharmaceutical products; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services; evaluation of pharmaceuticals; technological research, namely, pharmaceutical research |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, June 27, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt. |
US Class Codes | 001, 046 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, June 27, 2021 |
Primary Code | 031 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, June 27, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | CN |
Party Name | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | CN |
Party Name | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | CN |
Event Date | Event Description |
Saturday, March 25, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
Monday, October 10, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Sunday, September 4, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
Sunday, September 4, 2022 | GENERIC MADRID TRANSACTION CREATED |
Wednesday, August 3, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, May 3, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, February 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 15, 2022 | PUBLISHED FOR OPPOSITION |
Monday, February 14, 2022 | NOTIFICATION PROCESSED BY IB |
Wednesday, January 26, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, January 26, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, January 26, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Saturday, January 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, January 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, January 7, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, January 7, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, November 5, 2021 | REFUSAL PROCESSED BY IB |
Friday, October 8, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, October 8, 2021 | REFUSAL PROCESSED BY MPU |
Friday, September 24, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, September 23, 2021 | NON-FINAL ACTION WRITTEN |
Sunday, September 19, 2021 | ASSIGNED TO EXAMINER |
Thursday, July 1, 2021 | APPLICATION FILING RECEIPT MAILED |
Sunday, June 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 24, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |